2 results
Approved WMOCompleted
To test the use of RFA and ER in a single endoscopic session in 20 consecutive patients with a BE containing visible abnormalities with HGD or EC upon biopsy.
Approved WMOCompleted
Primary objectiveTo evaluate preliminary efficacy of itacitinib (INCB039110) on spleen volume reduction (SVR) from baseline at Week 24 in the 2 following cohorts of MF subjects:- Cohort A: in combination in subjects with ruxolitinib low dose (less…